Julz is attending the BioTrinity Conference in London on May 9-10, 2017.   BioTrinity is one of Europe’s leading biopartnering and investment conferences, and the largest of its type in the UK.  The conference provides a networking and partnering platform for life science companies across the world to meet under one roof and catalyze business in the industry, to ultimately help shape our healthcare future.  BioTrinity offers unique access to global life science investors, like Julz Co, big pharma executives and innovative CEO’s of emerging R&D companies seeking to make deals and grow their networks.

Julz Co is an investment management company focused on the health care industry with an emphasis on therapeutics, diagnostics, medical devices and digital healthcare. The company has offices in Chapel Hill, North Carolina, USA and Suzhou, China.  Julz typically invests in early stage biotechnology/medical device companies that have novel and proprietary technology addressing a vital market need and are driven by experienced management teams.